Golden
EFung Capital

EFung Capital

Shenzhen Efung Investment Management Co. Ltd.,(abbreviated as "Efung" or "Efung Capital") is one of Shenzhen's earliest professional venture capital firms and has been rated as"The Top Ten Venture Capital Institutions in Shenzhen" for many years.

Shenzhen Efung Investment Management (Efung Capital) is a Shenzhen based life science venture capital firm. They focus investments in clinical-stage pharmaceutical and medical device companies already generating revenues. They look for investment in China and the United States.



Investment

Efung Capital has made investments in WeMed, Elicio Therapeutics, TriArm Therapeutics, Zhongyianke Biotech, Tactiva Therapeutics, KBP Biosciences, Centrexion Therapeutics, Ascentage Pharma, Chipscreen Biosciences, Frontier Biotech, Lifotronic, Healthgen Biotech, Aridis Pharmaceuticals, and Resverlogix.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

Centrexion Therapeutics is a Boston-based company.

2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Frank Luo

Managing Director



Hao Li

Medical Strategy Officer



Hao Ye

Managing Director



Hualiang Jiang

Strategy Consultant



Hui Zhao

Principal



Jie Zhang

Partner



Jinhua Lu

Partner



Jinqiao Zhu

Chairman and President



Li Hua

Principal



Ning Lei

Managing Director



Pai Zhu

Assistant President



Ran Wang

Vice President



Ruina Wang

Managing Director



Sylvia Li

Analyst



Xiaoxiao Peng, PhD

Managing Director



Yu Lei

Managing Director



Yu Wang

Chief Scientist



Yuan Gao

Principal



Zhengli Ren

Partner



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References